Clinical Features and Outcomes in Patients with Localized High-Grade Synovial Sarcoma
Author Information
Author(s): H. Al-Hussaini, D. Hogg, M. E. Blackstein, B. O'Sullivan, C. N. Catton, P. W. Chung, A. M. Griffin, D. Hodgson, S. Hopyan, R. Kandel, P. C. Ferguson, J. S. Wunder, A. A. Gupta
Primary Institution: Princess Margaret Hospital, University of Toronto
Hypothesis
What is the impact of chemotherapy on survival in pediatric and adult patients with localized synovial sarcoma?
Conclusion
Patients with localized synovial sarcoma have a good chance of cure with surgery and radiation, but the role of chemotherapy in improving survival remains unclear.
Supporting Evidence
- 64% of patients had large tumors greater than 5 cm.
- 92.2% of patients had negative surgical margins after resection.
- 5-year event-free survival was 69.3% and overall survival was 80.3%.
- Chemotherapy was administered to 24.5% of patients, with varying response rates.
Takeaway
Doctors found that surgery and radiation work well for kids and adults with a type of cancer called synovial sarcoma, but using chemotherapy doesn't seem to help much.
Methodology
The study reviewed medical records of 102 patients with localized synovial sarcoma treated at two centers, analyzing treatment outcomes and survival rates.
Potential Biases
There may be biases due to the nonrandomized nature of treatment delivery.
Limitations
The study's findings are limited by the nonrandomized delivery of chemotherapy and the small sample size.
Participant Demographics
87 adult patients and 15 pediatric patients, with a median age of 37.6 years for adults and 14 years for children.
Statistical Information
P-Value
p=0.33
Confidence Interval
69.3 ± 4.8% for EFS and 80.3 ± 4.3% for OS
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website